What are the major updates in the 2024 European Society of Cardiology (ESC) guidelines for atrial fibrillation, heart failure with reduced ejection fraction, hypertension, valvular disease, and coronary artery disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: February 17, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

Can you summarize and critique the 2024 European Society of Cardiology guideline for management of atrial fibrillation?

Is the difference between acute and chronic atrial fibrillation (AF) now considered to be 24 hours rather than 48 hours in new guidelines?

What is the latest recommendation for the treatment of atrial fibrillation?

For a patient with persistent Atrial Fibrillation (AFib) and heart failure with reduced Ejection Fraction (EF) on metoprolol tartrate, is switching to metoprolol succinate or carvedilol better?

What is the recommended management approach for a 64-year-old male with paroxysmal atrial fibrillation, heart failure with reduced ejection fraction, and tachycardia, who is asymptomatic but has an irregularly irregular rhythm, and is currently on Eliquis (apixaban), metoprolol, and losartan?

How is cystic fibrosis-related obstructive azoospermia diagnosed and managed?

What is pigmented purpuric dermatosis?

In a patient with major depressive disorder who has not shown clinical improvement after an adequate trial of a selective serotonin reuptake inhibitor, what is the next step in management?

What laboratory tests should be ordered for a male patient with azoospermia suspected to be due to congenital bilateral absence of the vas deferens?

How should I manage brown‑black hyperpigmentation of the lower legs caused by hemosiderin deposition secondary to chronic venous insufficiency?

What are the dosing guidelines, maximum duration, contraindications, and side effects of Flexeril (cyclobenzaprine) for acute musculoskeletal muscle spasm?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.